Alterations in Memory and Impact on Academic Outcomes in Children Following Allogeneic Hematopoietic Cell Transplantation

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
R Lajiness-O'NeillJ A Connelly

Abstract

The prevalence of late effects following allogeneic hematopoietic cell transplantation (HCT), a curative treatment for pediatric leukemia, is high: 79% of HCT recipients experience chronic medical conditions. The few extant studies of cognitive late effects have focused on intelligence and are equivocal about HCT neurotoxicity. In an archival study of 30 children (mean transplant age = 6 years), we characterize neuropsychological predictors of academic outcomes. Mean intellectual and academic abilities were average, but evidenced extreme variability, particularly on measures of attention and memory: ∼25% of the sample exhibited borderline performance or lower. Medical predictors of outcome revealed paradoxically better memory associated with more severe acute graft-versus-host disease (GVHD) and associated with steroid treatment. Processing speed and memory accounted for 69% and 61% of variance in mathematics and reading outcomes, respectively. Thus, our findings revealed neurocognitive areas of vulnerability in processing speed and memory following HCT that contribute to subsequent academic difficulties.

References

Oct 1, 1986·Journal of Clinical and Experimental Neuropsychology·D P Waber, J M Holmes
Mar 2, 1997·Bone Marrow Transplantation·J H KramerM J Cowan
Aug 7, 2001·Frontiers in Bioscience : a Journal and Virtual Library·F D Armstrong
May 7, 2002·Journal of Pediatric Hematology/oncology·Steven SimmsNancy Bunin
Sep 19, 2003·Journal of Clinical and Experimental Neuropsychology·David W Collins, Byron P Rourke
Jan 1, 1994·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·M W OttoJ F Rosenbaum
Aug 26, 2006·Neuroscience and Biobehavioral Reviews·P W Kodituwakku
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sean PhippsMaggi Dunavant
Jan 1, 1997·European Psychiatry : the Journal of the Association of European Psychiatrists·J Cohen
Jun 25, 2013·Journal of the International Neuropsychological Society : JINS·Anne B ArnettShari L Wade
Dec 3, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nelli BejanyanMei-Jie Zhang

❮ Previous
Next ❯

Citations

Dec 24, 2016·Current Opinion in Supportive and Palliative Care·Amanda D HutchinsonCarlene Wilson
Nov 16, 2020·Bone Marrow Transplantation·Kendra R ParrisSean Phipps

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.